LncRNA HAR1A in triple-negative breast cancer: mechanisms and the role of polymorphism rs 6089838 in susceptibility

  • Published on 05/05/2026
  •  Reading time: 1 min.

Xiaobing Yi a,* , Lina Huang b,c,* , Linna Kong d , Xuena Yi d , Huihui Zhang d , Jiaqi Liu d & Lei Han e,*

a Department of Pathology, No.980 Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Shijiazhuang, China
b Department of Rehabilitation, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China
c Key Laboratory of Research and Development on Clinical Molecular Diagnosis for High-Incidence Diseases of Baise, Baise, Guangxi, China
d Department of Breast and Thyroid Surgery, Zibo Central Hospital, Zibo, China
e Breast Surgery, Fuzhou University Affiliated Fujian Provincial Hospital, Fuzhou, China

CONTACT Lei Han mailto:Leihan_FZ@163.com Breast Surgery, Fuzhou University Affiliated Fujian Provincial Hospital, No. 134, East Street, Fuzhou 350001, China

ContentGeneMD

To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Oncology

Receive our newsletter to stay up to date with the latest news in Oncology